Masked hypertension and echocardiographic left ventricular hypertrophy: An updated overview

Blood Pressure Monitoring

Volumn 17, Issue 1, 2012, Pages 8-13

  Cuspidi, Cesare ^a,b   Negri, Francesca ^a,b   Sala, Carla ^c,d   Mancia, Giuseppe ^a,b,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

left ventricular hypertrophy; masked hypertension; target organ damage

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART INDEX; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; MASKED HYPERTENSION; MEDLINE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MASKED HYPERTENSION; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84856025772     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32834f713a     Document Type: Article

References (33)

1. Parati G. Clinical relevance of masked hypertension. Am J Hypertens 2006; 19:887-888. (Pubitemid 46127411)
2. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressures in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783. (Pubitemid 40525142)
3. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield NJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
5. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796. (Pubitemid 35434896)
6. Bombelli M, Sega R, Facchetti R, Corrao G, Polo Friz H, Vertemati AM, et al. Prevalence and clinical significance of a greater ambulatory versus office blood pressure ("reversed white coat" condition) in a general population. J Hypertens 2005; 23:513-520. (Pubitemid 40684708)
7. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:479-488. (Pubitemid 47083117)
8. Angeli F, Reboldi G, Verdecchia P. Masked hypertension: evaluation, prognosis and treatment. Am J Hypertens 2010; 23:941-948.
9. Kawano Y, Horio T, Matayoshi T, Kamide K. Masked hypertension: subtypes and organ damage. Clin Exper Hypertens 2008; 30:289-296. (Pubitemid 351556174)
10. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572. (Pubitemid 29494086)
11. Bjorklund K, Lind L, Zhetelius B, Andren B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107:1297-1302. (Pubitemid 36314414)
12. Bobrie G, Chatellier G, Genes N, Clersun P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of) masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349. (Pubitemid 38541649)
13. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853. (Pubitemid 44297554)
14. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white coat, masked and sustained hypertension versus true normotension. J Hypertens 2007; 25:2193-2198. (Pubitemid 47537908)
15. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008; 26: 1715-1725.
16. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, et al. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006; 19:880-886. (Pubitemid 46106997)
17. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 2010; 21:137-144.
18. Sega R, Trocino G, Lanzaroti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general population (Pressioni Arteriose Monitorate E Loro Associazioni: PAMELA Study). Circulation 2001; 104:1385-1392. (Pubitemid 32880151)
19. Hernandez del Rey R, Armario P, Martin-Baranera M, Sanchez P, Almendros MC, Coca A, Pardell H. Cardiac damage in hypertensive patients with inverse white coat hypertension. Hospitalet Study. Blood Press 2003; 12:89-96. (Pubitemid 36700690)
20. Palatini P, Winnicki M, Santonastaso M, Mos L, Longo D, Zaetta V, et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension 2004; 44:170-174. (Pubitemid 39014234)
21. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005; 19:471-477. (Pubitemid 40767184)
22. Tomiyama M, Horio T, Kamide K, Nakamura S, Yoshibara F, Nakata H, et al. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. J Hum Hypertens 2007; 21:212-219.
23. Hoshide S, Ishikawa J, Eguchi K, Ojima T, Shimada K, Kario K. Masked nocturnal hypertension and target organ damage in hypertensives with well controlled self-measured home blood pressure. Hypertens Res 2007; 30:143-149. (Pubitemid 46541788)
24. Marchesi C, Maresca A, Solbiati F, Franzetti I, Laurita E, Nicolini E, et al. Masked hypertension in type 2 diabetes mellitus. Am J Hypertens 2007; 20:1079-1084.
25. Leitao CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Cross JL. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 2007; 30:1255-1260. (Pubitemid 46684656)
26. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens 2008; 21:393-399. (Pubitemid 351450863)
27. Konstantopoulou AS, Konstantopoulou PS, Papargyriou IK, Liatis ST, Stergiou GS, Papadogiannis DE. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters. J Hum Hypertens 2010; 24:151-157.
28. Sharman JE, Hare JL, Thomas S, Davies JE, Leano L, Jenkins C, Marwick TH. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens 2011; 24:898-903.
29. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415. (Pubitemid 36682819)
30. Wing LMH, Brwon MA, Beilin LJ, Ryan P, Reid CM. On behalf of the ANBP2 Management Committee and Investigators. "Reverse white-coat hypertension" in older hypertensives. J Hypertens 2002; 20:639-644.
31. Hanninen MRA, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 29:1980-1988.
32. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure monitoring: is the same phenomenon? Am J Hypertens 2005; 18:772-778. (Pubitemid 40745260)
33. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is a common as isolated clinic hypertension: predominance of younger men. Am J Hypertens 2005; 18:589-593. (Pubitemid 40692424)